Cargando…

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis

Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM). Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between Nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Liu, Lingjuan, Xiong, Jie, Zhang, Lu, Huang, Peng, Tang, Li, Xiao, Yangyang, Li, Xingfang, Li, Jian, Luo, Yingying, Li, Huiling, Mao, Dingan, Liu, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173107/
https://www.ncbi.nlm.nih.gov/pubmed/34093424
http://dx.doi.org/10.3389/fneur.2021.679430
_version_ 1783702655510511616
author Xu, Jie
Liu, Lingjuan
Xiong, Jie
Zhang, Lu
Huang, Peng
Tang, Li
Xiao, Yangyang
Li, Xingfang
Li, Jian
Luo, Yingying
Li, Huiling
Mao, Dingan
Liu, Liqun
author_facet Xu, Jie
Liu, Lingjuan
Xiong, Jie
Zhang, Lu
Huang, Peng
Tang, Li
Xiao, Yangyang
Li, Xingfang
Li, Jian
Luo, Yingying
Li, Huiling
Mao, Dingan
Liu, Liqun
author_sort Xu, Jie
collection PubMed
description Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM). Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between November 2015 and October 2020. Results: Twenty-eight pediatric patients and 25 adults were admitted to our study. Bilateral optic neuritis (BON) was the most common initial phenotype in the pediatric group but less common in the adult group (28.57 vs. 0%, p = 0.0119). Almost half of the adult patients presented with neuromyelitis optica spectrum disease (NMOSD), which was less prevalent among the pediatrics (48 vs. 21.43%, p = 0.0414). Visual impairment was the most common symptom in both groups during the initial attack (pediatric group, 39.29%; adult group, 64%) and throughout the full course (pediatric group, 57.14%; adult group, 72%). More pediatric patients suffered from fever than adult patients at onset (pediatric group, 28.57%; adult group, 4%; p = 0.0442) and throughout the full course (pediatric group, 39.29%; adult group, 12%; p = 0.0245). Multiple patchy lesions in subcortical white matter (pediatric group, 40.74%; adult group, 45%), periventricular (pediatric group, 25.93%; adult group, 35%), infratentorial (pediatric group, 18.52%; adult group, 30%) and deep gray matter (pediatric group, 25.93%; adult group, 20%) were frequent in all cases, no significant difference was found between the two groups, while bilateral optic nerve involvement was more frequent in pediatric group (61.54 vs. 14.29%, p = 0.0042) and unilateral optic nerve involvement was higher in adult group (64.29 vs. 15.38%, p = 0.0052). At the last follow-up, adult patients had a higher average EDSS score (median 1.0, range 0–3) than pediatrics (median 0.0, range 0–3), though not significant (p = 0.0752). Patients aged 0–9 years (61.54%) and 10–18 years (70%), and patients presenting with encephalitis/meningoencephalitis (100%) and ADEM (75%) were more likely to recover fully. Conclusions: Visual impairment was the dominant symptom in both pediatric and adult patients, while fever was more frequent in pediatric patients. Data suggested that BON and bilateral optic nerve involvement were more common in pediatric cases whereas NMOSD and unilateral optic nerve involvement were more prevalent in adults. The younger patients and patients presenting with encephalitis/meningoencephalitis and ADEM tended to recover better.
format Online
Article
Text
id pubmed-8173107
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81731072021-06-04 The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis Xu, Jie Liu, Lingjuan Xiong, Jie Zhang, Lu Huang, Peng Tang, Li Xiao, Yangyang Li, Xingfang Li, Jian Luo, Yingying Li, Huiling Mao, Dingan Liu, Liqun Front Neurol Neurology Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM). Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between November 2015 and October 2020. Results: Twenty-eight pediatric patients and 25 adults were admitted to our study. Bilateral optic neuritis (BON) was the most common initial phenotype in the pediatric group but less common in the adult group (28.57 vs. 0%, p = 0.0119). Almost half of the adult patients presented with neuromyelitis optica spectrum disease (NMOSD), which was less prevalent among the pediatrics (48 vs. 21.43%, p = 0.0414). Visual impairment was the most common symptom in both groups during the initial attack (pediatric group, 39.29%; adult group, 64%) and throughout the full course (pediatric group, 57.14%; adult group, 72%). More pediatric patients suffered from fever than adult patients at onset (pediatric group, 28.57%; adult group, 4%; p = 0.0442) and throughout the full course (pediatric group, 39.29%; adult group, 12%; p = 0.0245). Multiple patchy lesions in subcortical white matter (pediatric group, 40.74%; adult group, 45%), periventricular (pediatric group, 25.93%; adult group, 35%), infratentorial (pediatric group, 18.52%; adult group, 30%) and deep gray matter (pediatric group, 25.93%; adult group, 20%) were frequent in all cases, no significant difference was found between the two groups, while bilateral optic nerve involvement was more frequent in pediatric group (61.54 vs. 14.29%, p = 0.0042) and unilateral optic nerve involvement was higher in adult group (64.29 vs. 15.38%, p = 0.0052). At the last follow-up, adult patients had a higher average EDSS score (median 1.0, range 0–3) than pediatrics (median 0.0, range 0–3), though not significant (p = 0.0752). Patients aged 0–9 years (61.54%) and 10–18 years (70%), and patients presenting with encephalitis/meningoencephalitis (100%) and ADEM (75%) were more likely to recover fully. Conclusions: Visual impairment was the dominant symptom in both pediatric and adult patients, while fever was more frequent in pediatric patients. Data suggested that BON and bilateral optic nerve involvement were more common in pediatric cases whereas NMOSD and unilateral optic nerve involvement were more prevalent in adults. The younger patients and patients presenting with encephalitis/meningoencephalitis and ADEM tended to recover better. Frontiers Media S.A. 2021-05-20 /pmc/articles/PMC8173107/ /pubmed/34093424 http://dx.doi.org/10.3389/fneur.2021.679430 Text en Copyright © 2021 Xu, Liu, Xiong, Zhang, Huang, Tang, Xiao, Li, Li, Luo, Li, Mao and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Xu, Jie
Liu, Lingjuan
Xiong, Jie
Zhang, Lu
Huang, Peng
Tang, Li
Xiao, Yangyang
Li, Xingfang
Li, Jian
Luo, Yingying
Li, Huiling
Mao, Dingan
Liu, Liqun
The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_full The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_fullStr The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_full_unstemmed The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_short The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_sort clinical, radiologic, and prognostic differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173107/
https://www.ncbi.nlm.nih.gov/pubmed/34093424
http://dx.doi.org/10.3389/fneur.2021.679430
work_keys_str_mv AT xujie theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liulingjuan theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xiongjie theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT zhanglu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT huangpeng theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT tangli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xiaoyangyang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lixingfang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lijian theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT luoyingying theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lihuiling theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT maodingan theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liuliqun theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xujie clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liulingjuan clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xiongjie clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT zhanglu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT huangpeng clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT tangli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xiaoyangyang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lixingfang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lijian clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT luoyingying clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lihuiling clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT maodingan clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liuliqun clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis